HEATHER MACLEOD: Open Payments
NPI 1669644258 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 51 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $928 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $310 |
| Neurocrine BioSciences, Inc. | 6 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Alkermes, Inc. | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, REXULTI, FANAPT, LYBALVI, Jornay PM, Qelbree.
Industry payments across FL — which companies pay providers there.
